Nostopharma
Pre-clinicalNostopharma develops novel small molecule therapeutics targeting neurodegenerative and inflammatory diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Nostopharma develops novel small molecule therapeutics targeting neurodegenerative and inflammatory diseases.
Small Molecules